BaseSpace
Correlation
Engine-Public
Sign In
Register
Correlation Engine 2.0
Home
My Data
Bookmarks
Collaborations
Inbox
Import Your Data
QuickView
FAQ
What is QuickView?
What can my QuickView results tell me?
What are the sources for the General Info tab in QuickView?
More QuickView FAQs
Back to top
QuickView
Curated
Studies
Body
Atlas
Disease
Atlas
Pharmaco
Atlas
Knockdown
Atlas
Genetic
Markers
Pathway
Enrichment
Literature
Clinical
Trials
0
Meta-
Analysis
QuickView
Search sequence regions
(e.g.
Lymphocyte
,
Anticancer prodrugs
,
Rapamycin
,
rs3825942
,
EGFR
,
Coagulation
,
HIV infection
)
Organisms
Chromosomes
Start
Stop
Homo Sapiens
Mus Musculus
Rattus Norvegicus
C. Elegans
D. Melanogaster
Saccharomyces Cerevisiae
QuickView
Go back to main search
Bookmark
Forward
QuickView
for
Par-3 protein, human
(compound)
Summary
General Info
Genetic Markers
Most Correlated Genes
No genes found
Explore Genetic Markers Results
Pathway Enrichment
Most Correlated Biogroups
No biogroups found
Explore Pathway Enrichment Results
Curated Studies
Most Correlated Studies
No studies found
Explore Curated Studies Results
Literature
Most Relevant Literature
PARD3 drives tumorigenesis through activating Sonic Hedgehog signalling in tumour-initiating cells i…
Integrative analysis of cancer dependency data and comprehensive phosphoproteomics data revealed the…
Polarity protein Par3 sensitizes breast cancer to paclitaxel by promoting cell cycle arrest.
miR-559 Inhibits Proliferation, Autophagy, and Angiogenesis of Hepatocellular Carcinoma Cells by Tar…
PARD3-ALK: A novel ALK fusion gene identified in a patient with lung adenocarcinoma.
Explore Literature Results
Clinical Trials
Most Relevant Clinical Trials
M7824 in Subjects With HPV Associated Malignancies
Vorapaxar in the Human Endotoxemia Model
Evaluation of Meclizine Orodispersible Tablet Pharmacokinetic in Human Volunteers
A Phase 1, First Time in Human (FTIH) Study to Evaluate GSK3352589, a REarranged During Transfection…
Pharmacodynamic Study to Assess the Anti-proliferative Activity of the PARP Inhibitor Olaparib in Pa…
Explore Clinical Trials Results
search
→
result
search
→
result
See more about this page
See complete FAQ